-
-
-
-
-
-
-
Envoy Medical terminates $15M at-the-market equity facility
-
-
-
-
-
-
-
Envoy Medical Announces New Patents Expanding Intellectual Property Portfolio in Fully Implanted Hearing Technology
-
-
-
-
-
-
-
Envoy Medical Appoints Chas McKhann to Board of Directors
-
-
-
-
-
-
-
Envoy Medical Regains Compliance with Nasdaq Listing Requirement
-
-
-
-
-
-
-
Envoy Medical Announces Closing of Up to $78.0 Million Upsized Public Offering
-
-
-
-
-
-
-
Envoy Medical Completes First Set of Activations in Final Stage of Pivotal Clinical Study for its First-Of-Its-Kind Fully Implanted Acclaim(R) Cochlear Implant
-
-
-
-
-
-
-
Envoy Medical Announces First Three Patients Enrolled in Final Stage of Acclaim(R) Cochlear Implant Pivotal Clinical Trial
-
430,611 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

